BIOPORTO DIAGNOSTICS A/S: Financial statements 2024
CVR: 18645882
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 36,243,216 and a net result of DKK -110,908,377 compared with DKK -104,752,919 the year before. That is an increase of 17.1% compared with the year before. The profit margin was -306%. Equity in the 2024 report amounted to DKK -756,182,617. The company had 22 employees in the financial year.
- Revenue
- DKK 36,243,216
- Gross Profit
- DKK -8,336,577
- Profit/Loss
- DKK -110,908,377
- Equity
- DKK -756,182,617
- Total Assets
- DKK 20,389,179
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 36.2M | -8.3M | -110.9M | -756.2M | 22 |
| 2023 | 31M | -4.4M | -104.8M | -645.3M | 21 |
| 2022 | 29M | -13.2M | -81.8M | -540.5M | 20 |
| 2021 | 24.3M | -15.2M | -54.1M | -458.7M | 15 |
| 2020 | 23.2M | -10.6M | -42.6M | -404.6M | 16 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BIOPORTO DIAGNOSTICS A/S has published its annual report for 2023. Revenue came to DKK 30,958,179, and the net result was DKK -104,752,919.
As of January 22, 2024, Peter Mørch Eriksen has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of January 22, 2024, Gry Louise Husby Larsen has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of January 21, 2024, Peter Mørch Eriksen has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of January 9, 2024, Anthony Paul Pare has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of January 9, 2024, Peter Mørch Eriksen is registered as adm. dir. of BIOPORTO DIAGNOSTICS A/S.
As of January 9, 2024, Anthony Paul Pare has stepped down as adm. dir. of BIOPORTO DIAGNOSTICS A/S.
About BIOPORTO DIAGNOSTICS A/S
BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 28 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.